Furthermore, higher expression levels of both Nrf2 and HO-1 were associated with poorer overall survival, suggesting their potential as prognostic indicators for ccRCC patients (Table 2) [136]. Here, HMOX1 is linked to nonpapillary renal cell carcinoma.